Details

Autor(en) / Beteiligte

• Filardo, Thomas D
• Prasad, Namrata
• Waddell, Caroline J
• Persad, Neela
• Pellegrini, Jr, Gerald J
• Borne, Deborah
• Janssen, Julia
• Bejarano, Anamaría
• Marx, Grace E
• Mosites, Emily

Titel

Mpox vaccine acceptability among people experiencing homelessness in San Francisco - October-November 2022

Ist Teil von

• Vaccine, 2023-09, Vol.41 (39), p.5673-5677

Ort / Verlag

Netherlands: Elsevier Limited

Erscheinungsjahr

2023

Link zum Volltext

Quelle

Elsevier ScienceDirect Journals Complete

Beschreibungen/Notizen

• Mpox has affected many communities in the United States (U.S.), including people experiencing homelessness (PEH). Mpox vaccination has been an important tool to disrupt transmission and protect communities at risk of infection. To better understand mpox vaccine knowledge and attitudes, we surveyed 273 PEH and people accessing homeless service sites in San Francisco. Among 64 participants previously offered mpox vaccination, 38 (59 %) had received the vaccine. Among 209 participants not previously offered mpox vaccination, 108 (52 %) reported they would receive the vaccine. Vaccine acceptance was higher among transgender female participants and among male participants who reported male sex partner preference (MSM). Half of participants who declined vaccination identified that perception of personal risk and vaccine education may increase their likelihood of receiving an mpox vaccine. Leveraging trusted information sources to provide risk communication and vaccine education may increase vaccine uptake among PEH.